|
|
|
Insider
Information: |
Capello Jeffrey D |
Relationship: |
Director |
City: |
Wellesley |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
108,080 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$12,169,449 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
108,080 |
|
|
Total
Value |
$12,169,449 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Perkinelmer Inc |
PKI |
SVP & CFO |
2008-01-29 |
91,428 |
2004-01-27 |
0 |
Premium* |
|
Boston Scientific Corp |
BSX |
EVP & Chief Financial ... |
2013-11-27 |
447 |
2009-06-16 |
0 |
Premium* |
|
Tempest Therapeutics, Inc |
TPST |
Director |
2013-03-18 |
11,111 |
2013-03-18 |
0 |
Premium* |
|
Biogen Idec Inc |
BIIB |
EVP & Chief Financial ... |
2020-02-12 |
3,118 |
2019-01-02 |
0 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2024-06-13 |
1,976 |
2024-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
69 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PKI |
Perkinelmer Inc |
officerTitle |
|
2006-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,226 |
0 |
|
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-11-27 |
4 |
S |
$11.70 |
$1,270,583 |
D/D |
(108,595) |
447 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP & Chief Financial Officer |
|
2019-01-02 |
4 |
D |
$304.69 |
$126,142 |
D/D |
(414) |
917 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP & Chief Financial Officer |
|
2019-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,331 |
1,331 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP & Chief Financial Officer |
|
2020-01-02 |
4 |
D |
$294.20 |
$119,445 |
D/D |
(406) |
1,813 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2024-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,976 |
1,976 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP & Chief Financial Officer |
|
2020-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,302 |
2,219 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP & Chief Financial Officer |
|
2020-02-12 |
4 |
D |
$331.76 |
$203,701 |
D/D |
(614) |
3,118 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP & Chief Financial Officer |
|
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,919 |
3,732 |
0 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2013-03-18 |
4 |
B |
$9.00 |
$99,999 |
D/D |
11,111 |
11,111 |
2.39 |
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2004-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
|
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2004-03-03 |
4 |
AS |
$21.60 |
$270,000 |
D/D |
(12,500) |
20,000 |
|
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2004-11-03 |
4 |
AS |
$22.00 |
$366,674 |
D/D |
(16,667) |
20,000 |
|
- |
|
BSX |
Boston Scientific Corp |
SVP, Chief Accounting Officer |
|
2009-06-16 |
4 |
D |
$9.01 |
$83,892 |
D/D |
(9,311) |
20,014 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP, Chief Accounting Officer |
|
2010-02-24 |
4 |
D |
$7.80 |
$8,923 |
D/D |
(1,144) |
21,882 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP, Chief Accounting Officer |
|
2010-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,012 |
23,026 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP, Chief Accounting Officer |
|
2009-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,325 |
29,325 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2004-03-03 |
4 |
OE |
$8.16 |
$102,000 |
D/D |
12,500 |
32,500 |
|
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2004-11-03 |
4 |
OE |
$12.22 |
$203,671 |
D/D |
16,667 |
36,667 |
|
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2005-01-25 |
4 |
A |
$21.02 |
$364,087 |
D/D |
17,321 |
37,321 |
|
- |
|
PKI |
Perkinelmer Inc |
VP Finance & CAO |
|
2005-10-31 |
4 |
AS |
$22.00 |
$366,674 |
D/D |
(16,667) |
37,344 |
0 |
- |
|
PKI |
Perkinelmer Inc |
VP Finance & CAO |
|
2005-10-31 |
4 |
OE |
$12.22 |
$203,671 |
D/D |
16,667 |
54,011 |
0 |
- |
|
PKI |
Perkinelmer Inc |
SVP & CFO |
|
2007-01-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,334) |
54,246 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2010-06-16 |
4 |
D |
$6.10 |
$157,984 |
D/D |
(25,899) |
69,297 |
0 |
- |
|
PKI |
Perkinelmer Inc |
SVP & CFO |
|
2007-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,893 |
73,139 |
0 |
- |
|
69 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|